Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Vaccine Efficacy
92%
T Cell
62%
Natural Killer Cell
54%
Rhesus Monkey
48%
Macaca
39%
Antigen
37%
Vaccinia Virus
33%
Interleukin 15
29%
Cytokine
27%
Plasmid
25%
Replicon
18%
Monospecific Antibody
18%
Immunogenicity
17%
Heterologous Vaccine
16%
Natural Killer Cell Response
16%
Neutralizing Antibody
15%
Antibody Response
15%
Mycobacterium Bovis BCG
13%
Bacilli
13%
Auxotrophy
13%
Humoral Immunity
13%
Preclinical Study
13%
Myeloid
13%
Human Immunodeficiency Virus
13%
DNA Vaccine
13%
Alphavirus
13%
Atadenovirus
13%
B Cell
13%
Cytotoxic T-Cell
11%
Vaccination Policy
11%
CD4
11%
Electroporation
10%
Immune Response
10%
Mouse
8%
Adenoviridae
7%
Semliki Forest Virus
7%
Simian Virus
6%
Cladistics
6%
Epitope
6%
Infectious Agent
5%
Immunotherapy
5%
Rituximab
5%
Antibody-Dependent Cell-Mediated Cytotoxicity
5%
Multiple Myeloma
5%
Keyphrases
Human Immunodeficiency Virus Type 1 (HIV-1)
64%
Rhesus Macaque
42%
HIVconsv
40%
T Cells
29%
Immunogen
26%
Synthetic Peptides
25%
Modified Vaccinia Virus Ankara
22%
Conserved Regions
21%
Macaque
20%
Natural Killer Cells
18%
Prime-boost
18%
Enhanced Response
15%
Neutralizing Antibodies
15%
Adjuvanted
15%
Gp140
15%
Interleukin-15 (IL-15)
14%
Memory-like
13%
Conserved Protein
13%
Immunogenicity
13%
Heterotrimeric
13%
Free-selection
13%
Myeloid Leukemia
13%
Monovalent Cations
13%
HIV-1 Replication
13%
Humoral Response
13%
CD56bright NK Cells
13%
Heterologous Vaccine
13%
Bacillus Calmette
13%
CD56bright
13%
Neonate
13%
Novel Recombinant
13%
Anti-tumor Response
13%
Atadenovirus
13%
T Cell Vaccine
9%
Simian Adenovirus
7%
Acute Myeloid Leukemia
7%
Virus
6%
Epitope
6%
CD4 Cells
5%